Earnings Update: 3 Healthcare Giants

Earnings Update: 3 Healthcare Giants

Research  these Stocks on Kapitall’s Playground Now

research now

Three healthcare companies reported their earnings this morning and one of them, healthcare insurance provider Aetna (AET), came out with a strong positive earnings surprise. Pfizer (PFE) beat earnings estimates as well, but only by a cent. And at Merck & Co. (MRK) revenues were down, a result of disappointing sales of its diabetes and arthritis drugs.

Aetna's second-quarter earnings jumped by 17%, to $1.49 per share. The company adjusted its 2013 earnings to between $5.80 and $5.90, beating analyst ratings. 

Pfizer's earnings were up on the back of a strong rise in net income. However, much of the extra cash came from a patent settlement, and actual revenue fell just short of the $13.03 billion dollars estimated by analysts. 

Do you consider earnings reports when making investment decisions? Use the list below as a starting point for your own analysis. 


The List

1. Pfizer Inc. (PFE, Earnings, Analysts, Financials): Offers prescription medicines for humans and animals worldwide. Market cap at $212.3B, most recent closing price at $29.54.



2. Aetna Inc. (AET, Earnings, Analysts, Financials): Operates as a diversified health care benefits company in the United States. Market cap at $20.77B, most recent closing price at $63.40.



3. Merck & Co. Inc. (MRK, Earnings, Analysts, Financials): Provides various health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. Market cap at $146.08B, most recent closing price at $48.34.


(List compiled by James Dennin. Analyst ratings sourced from Zacks Investment Research, all other data sourced from Finviz.)


Analyze These Ideas: Getting Started

Dig Deeper: Access Company Snapshots, Charts, Filings

New to Kapitall?

1. New to the site? Click here to register for a free account, and gain access to more tools and data
2. Looking for more investing ideas like this? Click here to sign up for your free copy of Kapitall Weekly
3. Follow us on SeekingAlpha, TheStreet and Twitter


Kapitall Wire, which is not a broker/dealer, offers free cutting edge investing ideas, lively commentary and timely analysis of companies enhanced by interactive tools. And the Investing 101 section breaks complex concepts down to their basics, offering education to novices that doubles as a refresher course for more seasoned investors.

Kapitall Wire is a division of Kapitall Inc. Securities products and services are offered by Kapitall Generation, LLC, member FINRA/SIPC . Kapitall Generation, LLC is a wholly owned subsidiary of Kapitall, Inc.


Leave a Reply

Your email address will not be published. Required fields are marked *

  • See Most Recent Articles